CELGENE AVILOMICS RESEARCH
DEAD

Serial Number

85565444

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Mar 9, 2012

Add to watchlist:

No watchlists yet
View on USPTO

CELGENE AVILOMICS RESEARCH Trademark

Serial Number: 85565444 • Registration: 4291257

CELGENE AVILOMICS RESEARCH is a trademark filed by Celgene Corporation on March 9, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

March 9, 2012

Registration Date

February 19, 2013

Published for Opposition

December 4, 2012

Cancellation Date

September 20, 2019

Goods & Services

Downloadable software for designing covalent drugs for use in the fields of pharmaceutical research and bioinformatics; Downloadable computer graphics, photographs, animations, computer screen shots, and 3-D pictures; Downloadable audio and video files and multimedia files featuring design of covalent drugs; Downloadable data sets and databases featuring design of covalent drugs; Electronic downloadable publications in the nature of magazines, articles for magazines, features for magazines and newspapers, text files, newsletters, newspapers, news supplements, reports, brochures, circulars, periodicals, pamphlets, leaflets, technical papers, and abstracts, the foregoing in the fields of pharmaceutical research and bioinformatics for use by professionals in the fields of science and medicine; Downloadable electronic publications in the nature of magazines, articles for magazines, features for magazines and newspapers, text files, newsletters, newspapers, news supplements, reports, brochures, circulars, periodicals, pamphlets, leaflets, audio and video files, multimedia files, data sets, databases, computer screen shots, 3-D pictures, technical papers, and abstracts in the fields of pharmaceutical research and bioinformatics

pharmaceutical preparations for the treatment of oncology, autoimmune disease and inflammatory disorders

Pharmaceutical research and development services; research in the fields of biotechnology, chemistry and pharmaceuticals; research and testing services in the fields of biotechnology, chemistry and pharmaceuticals; research and development of new products for others in the fields of biotechnology, chemistry and pharmaceuticals; scientific research services

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 20, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 19, 2018 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Feb 19, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 4, 2012 NPUB
PUBLISHED FOR OPPOSITION
Dec 4, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 29, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2012 CRFA
ASSIGNED TO LIE
Sep 21, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2012 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2012 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2012 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Mar 17, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2012 NWOS
NEW APPLICATION ENTERED
Mar 13, 2012 NWAP